Tumor heterogeneity and strategies to overcome kinase inhibitor resistance in cancer: Lessons from melanoma
A). Pathway Switching: BRAF V600E melanoma cells chronically treated with BRAF inhibitors acquire drug resistance via switching between the three isoforms of RAF to activate the MAPK pathway. Establishment of IGFR1 and PDGFR signaling may also allow mutated BRAF to be bypassed. B) Pre-existing Clones: The presence of pre-existing mutations may affect the response of a tumor to BRAF kinase inhibition. NRAS mutated melanoma cells are not inhibited by BRAF inhibitors and may actually show increased growth, allowing the tumor to be repopulated. C) Intratumoral heterogeneity: Melanomas are highly heterogeneous tumors; a small subset of slow growing, JARID1b expressing melanoma cells have been observed with the ability to evade treatment, and may repopulate the heterogeneity of the tumor that existed prior to treatment. Targeted therapy toward the multiple phenotypes within a tumor may be required to adequately eliminate the whole tumor.
Publication
Tumor heterogeneity and strategies to overcome kinase inhibitor resistance in cancer: Lessons from melanoma. () Vito W. Rebecca, et al. Expert Opin Investig Drugs. ;20(2):137-140. Figure: F1.| Organism | Group | Word | Match | Source | NCBI Symbol | NCBI ID |
|---|---|---|---|---|---|---|
| Homo sapiens | Primates | BRAF | BRAF | ncbigene_symbol | BRAF | 673 |
| Homo sapiens | Primates | ARAF | ARAF | ncbigene_symbol | ARAF | 369 |
| Homo sapiens | Primates | RAS | RAS | famplex_relations | KRAS | 3845 |
| Homo sapiens | Primates | RAS | RAS | famplex_relations | HRAS | 3265 |
| Homo sapiens | Primates | RAS | RAS | famplex_relations | NRAS | 4893 |
| Homo sapiens | Primates | MEK | MEK | ncbigene_synonym | MAP2K7 | 5609 |
| Homo sapiens | Primates | MEK | MEK | famplex_relations | MAP2K1 | 5604 |
| Homo sapiens | Primates | MEK | MEK | famplex_relations | MAP2K2 | 5605 |
| Homo sapiens | Primates | CAF | CAF | ncbigene_synonym | KAT2B | 8850 |
| Homo sapiens | Primates | BRAP | BRAP | ncbigene_symbol | BRAP | 8315 |
| Homo sapiens | Primates | BRAP | BRAP | ncbigene_synonym | C6orf89 | 221477 |
| Homo sapiens | Primates | aRA | ARA | ncbigene_synonym | ABCC6 | 368 |
| Homo sapiens | Primates | aRA | ARA | ncbigene_synonym | FOXC1 | 2296 |
| Homo sapiens | Primates | aRA | ARA | ncbigene_synonym | PAK3 | 5063 |
| Drosophila melanogaster | Invertebrates | RAS | RAS | ncbigene_symbol | ras | 43873 |
| Drosophila melanogaster | Invertebrates | RAS | RAS | ncbigene_synonym | Ras64B | 38494 |
| Drosophila melanogaster | Invertebrates | RAS | RAS | ncbigene_synonym | Ras85D | 41140 |
| Drosophila melanogaster | Invertebrates | MEK | MEK | ncbigene_synonym | Dsor1 | 31872 |
| Drosophila melanogaster | Invertebrates | MEK | MEK | ncbigene_synonym | Mtk | 36708 |
| Drosophila melanogaster | Invertebrates | IRE | IRE | ncbigene_symbol | ire | 247514 |
| Drosophila melanogaster | Invertebrates | IRE | IRE | ncbigene_synonym | Ire1 | 42358 |
| Drosophila melanogaster | Invertebrates | CAF | CAF | ncbigene_synonym | Acf | 43751 |
| Drosophila melanogaster | Invertebrates | aRA | ARA | ncbigene_symbol | ara | 39439 |
| Danio rerio | Vertebrates | BRAF | BRAF | ncbigene_symbol | braf | 403065 |
| Danio rerio | Vertebrates | BRAF | BRAF | ncbigene_synonym | si:dkey-222f8.3 | 561722 |
| Danio rerio | Vertebrates | ARAF | ARAF | ncbigene_symbol | araf | 403063 |
| Danio rerio | Vertebrates | RAS | RAS | ncbigene_synonym | rab1ab | 368883 |
| Danio rerio | Vertebrates | BRAP | BRAP | ncbigene_symbol | brap | 436739 |
| Word | Match | MeSH | Name | ChEBI |
|---|
Disease mentions
| Word | Match | MeSH | Name | DOID |
|---|